Nectin‐2 was reduced in CD138+ plasma cells obtained from MM patients compared to those from HD or MGUS patients and was positively correlated with the OS of MM patients treated with bortezomib in Mulligan's cohort (Figure S3E,F, Supporting Information). The gene discussed is NECTIN2; the disease is Miyoshi myopathy.